Publications by authors named "N Jean-Paul Kabore"
Article Synopsis
- Campylobacter spp. is a major cause of bacterial gastroenteritis worldwide, but its impact in Burkina Faso is underreported due to poor surveillance.
- A study conducted from 2018 to 2021 analyzed fecal samples from 1,295 patients with acute gastroenteritis, using molecular techniques to identify Campylobacter species.
- Results showed that 25% of samples tested positive for Campylobacter, predominantly in children under 5, highlighting the need for improved surveillance to monitor this public health issue.
Article Synopsis
- Viral gastrointestinal infections are a significant health issue in developing countries, including Burkina Faso, where limited data on the circulating viruses and their genetic diversity exist.
- This study analyzed stool samples from 1,295 patients between 2018 and 2021, finding that 34.1% had detectable viruses, with norovirus and sapovirus being the most common.
- The research highlights a reduction in viral prevalence but a high diversity of strains, emphasizing the need for routine surveillance and improved management strategies for diarrhea, particularly for children.
In Burkina Faso, the health system is characterized by systemic insufficient and antiquated health-care infrastructures. Consequently, few health-care establishments have the required resources to diagnose and manage patients with COVID-19, and fewer still have intensive care facilities for severely ill patients with COVID. Furthermore, there is a widespread scarcity of qualified health-care staff.
View Article and Find Full Text PDFThe burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Influenza Other Respir Viruses
November 2023
Background: This study aimed to estimate the anti-SARS-CoV-2 antibody seroprevalence in the general population of Bobo-Dioulasso and Ouagadougou (Burkina Faso).
Methods: We collected from March to April 2021 blood samples from randomly selected residents in both main cities based on the World Health Organization (WHO) sero-epidemiological investigations protocols and tested them with WANTAI SARS-CoV-2 total antibodies enzyme-linked immunosorbent assay (ELISA) kits intended for qualitative assessment. We also recorded participants' socio-demographic and clinical characteristics and information on exposure to SARS-CoV-2.
The WHO Unity Studies initiative engaged low- and middle-income countries in the implementation of standardised SARS-CoV-2 sero-epidemiological investigation protocols and timely sharing of comparable results for evidence-based action. To gain a deeper understanding of the methodological challenges faced when conducting seroprevalence studies in the African region, we conducted unstructured interviews with key study teams in five countries. We discuss the challenges identified: participant recruitment and retention, sampling, sample and data management, data analysis and presentation.
View Article and Find Full Text PDF